However, a positive decision would allow state-licensed 503A compounding pharmacies to use the substances in compounded medicines , subject to the requirements governing pharmaceutical compounding
Originally approved by the FDA in 2017 as a type 2 diabetes treatment, four years later the FDA approved a higher dosage of semaglutide as a weight loss medication for treating obesity or overweight conditions in individuals with weight-related health issues like cardiovascular disease
Sensitivity analyses supported the findings from the primary analysis (Fig
Clinical trials show that retatrutide can help people get better weight loss and weight reduction than many other choices
While these pharmacovigilance findings underscore the need for heightened clinical vigilance, they represent associations rather than causal relationships, constrained by inherent limitations of FAERS such as reporting bias and confounding
Younger participants (1849 years) exhibited a higher risk of suicidal ideations or attempts (3.01, 95% CI: 2.703.37), while older participants ( 70 years) had a lower overall risk of psychiatric diseases (1.71, 95% CI: 1.611.82)